Mitigating lung damage, mortality due to SARS-CoV-2

Researchers report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and death in mice infected with the SARS-CoV-2 virus, which causes COVID-19 in humans.


Click here for original story, Mitigating lung damage, mortality due to SARS-CoV-2


Source: ScienceDaily